In vitro activity of BAY v 3522, a new oral cephalosporin.
The in vitro activity of BAY v 3522 was compared with the activities of cephalexin, cefaclor, cefuroxime, cefixime, and amoxicillin-clavulanate. MICs (in micrograms/ml) of BAY v 3522 were as follows: Staphylococcus spp. (except for oxacillin-resistant strains), 0.13 to 1; Streptococcus spp. (except...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1990
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171948/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2126697/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.9.1855 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|